Fundamental Valuation Report BP Midstream Partners(BPMP:NYS) Energy:Oil & Gas Midstream This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$12.79 (USD) 04/16/2021 Weighted Valuation$13.47 (USD) Overall RatingUndervalued by 5.3% Valuation Models …
BP Midstream Partners (BPMP:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Albireo Pharma(ALBO:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$32.92 (USD) 04/15/2021 Weighted Valuation$31.89 (USD) Overall RatingFairly valued to slightly Overvalued by 3.1% Valuation Models Adjusted …
Albireo Pharma (ALBO:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Alector(ALEC:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$18.48 (USD) 04/15/2021 Weighted Valuation$18.21 (USD) Overall RatingFairly valued to slightly Overvalued by 1.5% Valuation Models Comparables: $14.55 (USD) …
Alector (ALEC:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Allogene Therapeutics(ALLO:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$32.86 (USD) 04/15/2021 Weighted Valuation$36.86 (USD) Overall RatingUndervalued by 12.2% Valuation Models Adjusted Book Value: $36.87 (USD) …
Allogene Therapeutics (ALLO:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Alarm.com Holdings(ALRM:NAS) Technology:Software – Application This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$94.16 (USD) 04/15/2021 Weighted Valuation$88.50 (USD) Overall RatingOvervalued by 6.0% Valuation Models Adjusted Book …
Alarm.com Holdings (ALRM:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Altimmune(ALT:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$12.73 (USD) 04/15/2021 Weighted Valuation$9.89 (USD) Overall RatingOvervalued by 22.3% Valuation Models Comparables: $15.08 (USD) (in order of …
Altimmune (ALT:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Amedisys(AMED:NAS) Healthcare:Medical Care Facilities This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$283.99 (USD) 04/15/2021 Weighted Valuation$228.18 (USD) Overall RatingOvervalued by 19.7% Valuation Models Multiples: $191.51 (USD) Comparables: $177.85 …
Amedisys (AMED:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Amarin Corp(AMRN:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$5.01 (USD) 04/15/2021 Weighted Valuation$5.93 (USD) Overall RatingUndervalued by 18.4% Valuation Models Comparables: $5.93 (USD) Valuation Methods …
Amarin Corp (AMRN:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report American Tower(AMT:NYS) Real Estate:REIT – Specialty This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$247.16 (USD) 04/15/2021 Weighted Valuation$243.96 (USD) Overall RatingFairly valued to slightly Overvalued by 1.3% …
American Tower (AMT:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Aclaris Therapeutics(ACRS:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$27.82 (USD) 04/14/2021 Weighted Valuation$9.19 (USD) Overall RatingOvervalued by 67.0% Valuation Models Comparables: $9.19 (USD) Valuation Methods …
Aclaris Therapeutics (ACRS:NAS) Fundamental Valuation Report Read more »
Read More